Tuberculosis reactivation in a patient receiving anti-programmed death-1 (PD-1) inhibitor for relapsed Hodgkin's lymphoma

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Acta oncologica 2016-01, Vol.55 (4), p.519-520
Hauptverfasser:	Lee, Joycelyn J X, Chan, Alexandre, Tang, Tiffany
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged, 80 and over Antibodies, Monoclonal, Humanized - administration & dosage Antibodies, Monoclonal, Humanized - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Antitubercular Agents - therapeutic use Hodgkin Disease - drug therapy Hodgkin Disease - microbiology Hodgkin Disease - pathology Humans Lymph Nodes - diagnostic imaging Lymph Nodes - pathology Male Molecular Targeted Therapy Mycobacterium tuberculosis - isolation & purification Mycobacterium tuberculosis - pathogenicity Neoplasm Recurrence, Local Programmed Cell Death 1 Receptor - antagonists & inhibitors Tomography, X-Ray Computed Tuberculosis - chemically induced Tuberculosis - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!